Retraction: MicroRNA-433 inhibits oral squamous cell carcinoma cells by targeting FAK

PDF  |  How to cite

Oncotarget. 2022; 13:1033-1033. https://doi.org/10.18632/oncotarget.28270

Metrics: PDF 604 views  |   ?  

Yong-Jian Wang1,*, Zi-Feng Zhang1,*, Shao-Hua Fan1, Juan Zhuang1,2,3, Qun Shan1, Xin-Rui Han1, Xin Wen1, Meng-Qiu Li1, Bin Hu1, Chun-Hui Sun1, Bin Qiao4, Qian Tao4, Dong-Mei Wu1, Jun Lu1 and Yuan-Lin Zheng1

1Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou 221116, P.R. China
2School of Environment Science and Spatial Informatics, China University of Mining and Technology, Xuzhou 221008, P.R. China
3Jiangsu Key Laboratory for Eco-Agricultural Biotechnology around Hongze Lake, School of Life Sciences, Huaiyin Normal University, Huaian 223300, P.R. China
4Department of Oral and Maxillofacial Surgery, Guanghua School and Hospital of Stomatology, Guangdong Provincial Key Laboratory of Oral Diseases, Sun Yat-Sen University, Guangzhou 510055, P.R. China
*These authors have contributed equally to this work

Published: September 14, 2022

Copyright: © 2022 Wang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has been retracted: In July of 2020, the Academic Committee of Jiangsu Normal University launched an investigation into this paper and requested that the authors provide the original experimental records and data for verification. To date, however, the authors have failed to provide the requested documents. The committee has concluded that this paper displays signs of academic fraud. In light of this, the paper is retracted. The University and Oncotarget thank the Pubpeer community for raising the concerns.

Original article: Oncotarget. 2017; 8:100227–100241. DOI: https://doi.org/10.18632/oncotarget.22151.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28270